Search

everythinglearnresearchcommunity

for

Search:↓

Alefacept showed some effectiveness for alopecia areata but needs more research.

Minoxidil and caffeine in transfersomes improve hair growth treatment.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Type I interferons play a key role in the development of various skin diseases.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Menopause affects hair and skin; more research needed for treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Optimized film improves finasteride skin absorption and treatment efficiency.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

5% minoxidil works better for hair growth than 1% minoxidil.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.